Search results
Results from the WOW.Com Content Network
Pages in category "Defunct companies based in New York (state)" The following 177 pages are in this category, out of 177 total. This list may not reflect recent changes .
The New York City Economic Development Corporation's Early Stage Life Sciences Funding Initiative and venture capital partners, including Celgene, General Electric Ventures, and Eli Lilly, committed a minimum of US$100 million to help launch 15 to 20 ventures in life sciences and biotechnology in 2014, [6] and in January 2018, the City of New ...
Pages in category "Defunct companies based in New York City" The following 200 pages are in this category, out of approximately 207 total. This list may not reflect recent changes .
Legacy.com is a United States–based website founded in 1998, [2] the world's largest commercial provider of online memorials. [3] The Web site hosts obituaries and memorials for more than 70 percent of all U.S. deaths. [4] Legacy.com hosts obituaries for more than three-quarters of the 100 largest newspapers in the U.S., by circulation. [5]
Pharmacia & Upjohn was a global pharmaceutical company formed by the merger of Sweden-based Pharmacia AB and the American company Upjohn in 1995. [1] Today the remainder of the company is owned by Pfizer. In 1997, Pharmacia & Upjohn sold several brands to Johnson & Johnson, including Motrin and Cortaid.
Forest Laboratories was a company in the pharmaceutical industry incorporated in Delaware, with its principal office in New York City. It was known for licensing European pharmaceuticals for sale in the United States. On July 1, 2014, the company was acquired by Actavis (now Allergan).
In 2001, the US Department of Justice, states attorneys general, and TAP Pharmaceutical Products settled criminal and civil charges against TAP related to federal and state medicare fraud and illegal marketing of the drug leuprorelin. TAP paid a total of $875 million, which was a record high at the time. [5] [6]
The two companies discussed a potential merger, uniting two of the largest pharmaceutical companies. This was eventually thwarted by Pfizer, in order to maintain control of the blockbuster drug - Lipitor. [20] [21] 8 2016 Bayer AG: Monsanto Company Inc. 65 83